G0-G1 transition and the restriction point in pancreatic β-cells in vivo

Diabetes. 2014 Feb;63(2):578-84. doi: 10.2337/db12-1035. Epub 2013 Oct 15.

Abstract

Most of our knowledge on cell kinetics stems from in vitro studies of continuously dividing cells. In this study, we determine in vivo cell-cycle parameters of pancreatic β-cells, a largely quiescent population, using drugs that mimic or prevent glucose-induced replication of β-cells in mice. Quiescent β-cells exposed to a mitogenic glucose stimulation require 8 h to enter the G1 phase of the cell cycle, and this time is prolonged in older age. The duration of G1, S, and G2/M is ~5, 8, and 6 h, respectively. We further provide the first in vivo demonstration of the restriction point at the G0-G1 transition, discovered by Arthur Pardee 40 years ago. The findings may have pharmacodynamic implications in the design of regenerative therapies aimed at increasing β-cell replication and mass in patients with diabetes.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • G1 Phase / physiology*
  • Glucokinase
  • Insulin-Secreting Cells / physiology*
  • Male
  • Mice
  • Mice, Inbred ICR
  • Resting Phase, Cell Cycle / physiology*
  • S Phase / physiology

Substances

  • Glucokinase